Article
Lentiviral Gene Therapy for Cystic Fibrosis: A Promising Approach and First-in-Human Trial.
American journal of respiratory and critical care medicine - 15 Dec 2024
Davies Jane C, Polineni Deepika, Boyd A Christopher, Donaldson Scott, Gill Deborah R, Griesenbach Uta, Hyde Stephen C, Jain Raksha, McLachlan Gerry, Mall Marcus A, Alton Eric W F W
Abstract excerpt
Cystic fibrosis (CF) is a genetic disease caused by mutations in the CFTR (cystic fibrosis transmembrane conductance regulator) gene. Although CF is a multiorgan disease, the leading causes of morbidity and mortality are related to progressive lung disease. Current understanding of the effects of the broad spectrum of CFTR mutations on CFTR function has allowed for the development of CFTR modulator therapies....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
